Billets de Michelle Dawson

Billet publié sur Twitter/X le 01/02/2021 02:40

Twitter/X Essai clinique clinicaltrials.gov Extrait cité dans le billet Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

Liens cités structurés

1 ressource citée

Essai clinique Récupéré Publication clinicaltrials.gov

Institut National de la Santé Et de la Recherche Médicale, France (2021). Study of the Genetic Factors Involved in Autism and Related Disorders. ClinicalTrials.gov. Institut National de la Santé Et de la Recherche Médicale, France.

Date de publication
30/03/2021
Identifiant
NCT04727489
Auteurs
Institut National de la Santé Et de la Recherche Médicale, France
Source
ClinicalTrials.gov
Type de référence
clinical_trial
Éditeur
Institut National de la Santé Et de la Recherche Médicale, France
Source de métadonnées
clinicaltrials.gov

Résumé

The main objective of the study is to define, for Autism Spectrum Disorder, the extent of genetic variation in synaptic pathways that may be targeted for therapeutic development. For this purpose the investigators will take advantage of large, well-characterized cohorts of patients with Autism Spectrum Disorder for genetic screenings. Targeted sequencing of selected synaptic genes, previously associated with Autism Spectrum Disorder, will be carried out in these cohorts with deep coverage of coding regions and a strong focus on previously untested regulatory regions. Genomic data from Copy Number Variant, whole genome sequencing and exome sequencing, available for some of these patients, will be integrated in the overall analysis. The investigators will strongly emphasize the establishment of comprehensive genotype/phenotype correlations.